GEOLOGY OF DAY DOME (MADISON COUNTY, TEXAS). A STUDY OF SALT EMPLACEMENT.BORNHAUSER M.1969; AMER. ASS. PETROLEUM GEOLOGISTS BULL.; USA; 1969(7), VOL. 53, NUM. 0007, P. 1411 A 1420Miscellaneous

Induction of Toll-like receptor 2 and 4 expression on CD4⁺and CDS⁺ T cells in G-CSF-mobilized unrelated peripheral blood stem cell grafts during leukapheresis : impact on patient outcomePLATZBECKER, U; STOEHLMACHER, J; BORNHÄUSER, M et al.Leukemia. 2008, Vol 22, Num 7, pp 1438-1440, issn 0887-6924, 3 p.Article

Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation: a retrospective analysisSCHETELIG, J; BORNHÄUSER, M; BEELEN, D et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 5, pp 483-490, issn 0268-3369, 8 p.Article

Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysisBORNHÄUSER, M; ORDEMANN, R; PAAZ, U et al.Bone marrow transplantation (Basingstoke). 1997, Vol 19, Num 3, pp 295-297, issn 0268-3369Article

Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cellsSTAMOVA, S; CARTELLIERI, M; RIEBER, E. P et al.Leukemia. 2011, Vol 25, Num 6, pp 1053-1056, issn 0887-6924, 4 p.Article

Antiviral treatment of Influenza A (H1N1-09) guided by molecular resistance testing in aplasia after allo-SCTSHAYEGI, N; SCHWEIGER, B; DUWE, S et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 11, pp 1492-1494, issn 0268-3369, 3 p.Article

Successful treatment of molecular relapse in NPM1-positive AML using 5-azacytidineWERMKE, M; THIEDE, C; KIANI, A et al.Leukemia. 2010, Vol 24, Num 1, pp 236-237, issn 0887-6924, 2 p.Article

Evidence for a graft-versus-tumor effect in refractory ovarian cancerHÄNEL, M; BORNHÄUSER, M; MÜLLER, J et al.Journal of cancer research and clinical oncology. 2003, Vol 129, Num 1, pp 12-16, issn 0171-5216, 5 p.Article

Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantationWASSMANN, B; SCHEURING, U; OTTMANN, O. G et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 7, pp 611-614, issn 0268-3369, 4 p.Article

Computer-based quality control in high-dose chemotherapy and bone marrow transplantationBORNHÄUSER, M; SCHMIDT, M; EHNINGER, U et al.Bone marrow transplantation (Basingstoke). 1998, Vol 21, Num 5, pp 505-509, issn 0268-3369Article

Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with < 10% BM blasts: a report from EBMTMARTINO, R; DE WREEDE, L; DE WITTE, T et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 6, pp 761-770, issn 0268-3369, 10 p.Article

Acute myeloid leukemia cells fail to activate native human dendritic cells: a potential mechanism of immune evasionWEHNER, R; SCHUMACHER, P; BORNHÄUSER, M et al.Leukemia. 2010, Vol 24, Num 11, pp 1965-1967, issn 0887-6924, 3 p.Article

Busulfan, cyclophosphamide, and etoposide e as high-dose conditioning regimen in patients with malignant lymphomaHÄNEL, M; KRÖGER, N; HOFFKNECHT, M. M et al.Annals of hematology (Print). 2002, Vol 81, Num 2, pp 96-102, issn 0939-5555Article

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseARNOLD, R; MASSENKEIL, G; KOLB, H. J et al.Leukemia. 2002, Vol 16, Num 12, pp 2423-2428, issn 0887-6924, 6 p.Article

Foscarnet: an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?ORDEMANN, R; NAUMANN, R; GEISSLER, G et al.Annals of hematology (Print). 2000, Vol 79, Num 8, pp 432-436, issn 0939-5555Article

Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subtractions of patients with acute and chronic myeloid leukemiasBRENDEL, C; MOHR, B; SCHIMMELPFENNIG, C et al.Leukemia. 1999, Vol 13, Num 11, pp 1770-1775, issn 0887-6924Conference Paper

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseasesPLATZBECKER, U; EHNINGER, G; SCHMITZ, N et al.Annals of hematology (Print). 2003, Vol 82, Num 8, pp 463-468, issn 0939-5555, 6 p.Article

CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and functionJING, D; OELSCHLAEGEL, U; ORDEMANN, R et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 10, pp 1489-1496, issn 0268-3369, 8 p.Article

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing mediumVON BONIN, M; STÖLZE, F; KIANI, A et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 3, pp 245-251, issn 0268-3369, 7 p.Article

Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cellsSTRAUBE, C; WEHNER, R; WENDISCH, M et al.Leukemia. 2007, Vol 21, Num 7, pp 1464-1471, issn 0887-6924, 8 p.Article

Accidental busulfan overdose during conditioning for stem cell transplantationJENKE, A; FREIBERG-RICHTER, J; WILHELM, S et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 2, pp 125-128, issn 0268-3369, 4 p.Article

Activity of sirolimus in patients with myelodysplastic syndrome: results of a pilot studyPLATZBECKER, U; HAASE, M; HÄNEL, M et al.British journal of haematology. 2005, Vol 128, Num 5, pp 625-630, issn 0007-1048, 6 p.Article

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factorSAYER, H. G; KRÖGER, M; MARTIN, H et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 12, pp 1089-1095, issn 0268-3369, 7 p.Article

Severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantationSCHAICH, M; SCHÄKEL, K; ILLMER, T et al.Annals of hematology (Print). 2003, Vol 82, Num 5, pp 303-304, issn 0939-5555, 2 p.Article

Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipientsKIEHL, M. G; SCHÄFER-ECKART, K; SHIPKOVA, M et al.Transplantation proceedings. 2002, Vol 34, Num 7, pp 2922-2924, issn 0041-1345, 3 p.Conference Paper